Answers are grounded in this paper and cite their sources.
AIM: To evaluate the economic value of advanced practice nursing in the management of non-communicable diseases. DESIGN: Systematic review without meta-analysis. METHODS: Six databases were searched. Title/abstract and full-text screening, and data extraction were performed independently by two reviewers, with disagreements resolved by a third reviewer. Risk of bias was assessed using RoB 2.0 and ROBINS-I; economic reporting quality was assessed using CHEERS 2022. Certainty of evidence was rated using GRADE. DATA SOURCES: PubMed, Scopus, Web of Science, CINAHL, Cochrane Library and EconLit searched from 2012 to March 2026. RESULTS: Twenty studies published between 2012 and 2025 were included, most reporting favourable economic outcomes to advanced practice nursing, although results varied by economic perspective and time horizon. CONCLUSION: Advanced practice nursing is a clinically effective and economically efficient response to the growing burden of non-communicable diseases, despite heterogeneous results and limited evidence from low- and middle-income countries. IMPLICATIONS FOR THE PROFESSION AND/OR PATIENT CARE: Advanced practice nursing offers an efficient response to chronic disease management, supporting its wider implementation, particularly in under-resourced settings. IMPACT: This review addresses the lack of up-to-date evidence on the economic efficiency of advanced practice nursing in chronic disease management. Efficiency was generally favourable but context-sensitive, with implications for nursing workforce planning and health policy. REPORTING METHOD: PRISMA 2020, supplemented by Synthesis Without Meta-analysis guidance. PATIENT OR PUBLIC CONTRIBUTION: No patient or public contribution. TRIAL REGISTRATION: PROSPERO: CRD420261336116.
No takes yet. Share an insight, caveat, or question.
Lokossou et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: